Bitwise has launched a new exchange-traded product on the Deutsche Börse Xetra. The ETP offers investors exposure to AI-based blockchain NEAR with staking benefits. According to a press release sent to crypto.news, the crypto asset manager has launched its first…Bitwise has launched a new exchange-traded product on the Deutsche Börse Xetra. The ETP offers investors exposure to AI-based blockchain NEAR with staking benefits. According to a press release sent to crypto.news, the crypto asset manager has launched its first…

Bitwise NEAR Staking ETP makes Xetra debut today

3 min read

Bitwise has launched a new exchange-traded product on the Deutsche Börse Xetra. The ETP offers investors exposure to AI-based blockchain NEAR with staking benefits.

According to a press release sent to crypto.news, the crypto asset manager has launched its first NEAR Staking ETP on Deutsche Börse’s Xetra platform. The product is meant to attract both institutional and retail investors who are looking to diversify their portfolios by investing in products grounded in digital assets.

Marked with the ticker NEAR; ISIN DE000A4A5GV2, the NEAR (NEAR) Staking ETP is fully backed and issued in Germany, offering exposure to crypto assets as well as staking returns with low cost of ownership. The ETP is designed to accumulate daily staking yields.

The addition of its NEAR Staking ETP marks the fourth Bitwise ETP to make its debut in Europe, as part of the platform’s European Total Return product suite including the already established Bitwise Ethereum (ETH) Staking ETP.

However, the platform’s Ethereum Staking ETP has experienced a delay in its long-anticipated U.S. launch after the U.S. Securities and Exchange Commission announced it would extend its review of Bitwise’s proposal on July 1.

For investors, the NEAR Staking ETP can offer them exposure to staking rewards without having to manage the technical details of staking or token custody. This means that they can bypass having to hold NEAR directly or using third party wallets or validators.

In addition, the ETP offers benefits for investors which include daily liquidity, as it is traded on regulated stock exchanges and does not prescribe to any lock-up periods or manual delegation.

Additionally, the underlying NEAR tokens are held in cold storage by an institutional custodian.

Head of Europe at Bitwise, Bradley Duke, said that the platform is excited to launch the new ETP in partnership with NEAR, a blockchain that makes AI technology accessible.

“The Bitwise NEAR Staking ETP gives investors exposure to price movements in the NEAR token as well as compounded return from staking rewards all with Bitwise’s best-in-class ETP structure,” said Duke in his statement.

NEAR Protocol is a layer1 blockchain that is designed to make AI and other technological advancements accessible and useful for on-chain users. Established in 2020, NEAR addresses common challenges in blockchain by using sharding technology that enables the network to process many transactions at once.

The deployment of this technology is able to solve the problems of slow transaction processing and high costs.

In addition, developers can benefit from NEAR’s customizable smart contracts support multichain financial applications using secure cryptographic tools without the need for bridges or wrapped tokens.

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1,18
$1,18$1,18
-2,15%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29